Director, CEO and Chairman · Adaptive Biotechnologies Corp · Common Stock
Side
SELL
Value
$2.37M
Shares
125.0K
Price
$18.94
Executed
Dec 1, 2025
Disclosed
Dec 1, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Dec 1 executedDec 1, 2025 disclosed
ADPT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Robins Chad M filed this Form 4 reporting a open-market sale of ADPT on Dec 1, 2025. It became public on Dec 1, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO and Chairman
Robins Chad Mcik:0001780649
Issuer
Adaptive Biotechnologies Corpcik:0001478320
Revision history · 0
No field has changed since this record was first ingested.
